Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.

Gastroenterol Rep (Oxf) · 2015 · PMC4650974 · PMID 26290512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Better oncological outcomes were achieved in SG2, in terms of overall pathological response ( P = 0.02178) and pathological T-stage ( P = 0.0008); pCR was more common in SG2 (25%) than in SG1 (18%) but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.